Simulations Plus to Participate in 21st Annual Craig-Hallum Institutional Investor Conference

Rhea-AI Summary

Simulations Plus (Nasdaq: SLP), a leader in modeling and simulation solutions across various industries, will participate in the 21st Annual Craig-Hallum Institutional Investor Conference on May 29, 2024, in Minneapolis. CEO Shawn O'Connor will represent the company, engaging in one-on-one and small group meetings. This event features over 130 public companies, offering institutional clients the opportunity to meet with corporate management. Attendance is by invitation only.

Positive

• Participation in a high-profile conference increases visibility among institutional investors.
• Opportunity for CEO to engage directly with potential investors can foster new relationships.
• Showcasing at an event with over 130 public companies can enhance the company's market position.

Negative

• Attendance by invitation only limits broader investor engagement opportunities.
• No immediate financial or performance-related benefits specified.

LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced that Shawn O’Connor, chief executive officer, will participate in Craig-Hallum’s 21^st Annual Institutional Investor Conference on Wednesday, May 29, 2024, in Minneapolis, MN. Mr. O’Connor will host one-on-one and small group meetings throughout the day.

Each year, Craig-Hallum hosts a multi-industry investor conference featuring more than 130 public companies where institutional clients can meet formally with corporate management. Attendance is by invitation only. For more information about the conference, please visit the Craig-Hallum conference website.

About Simulations Plus

Serving clients worldwide for more than 25 years, Simulations Plus is a leading provider in the biosimulation market providing software and consulting services supporting drug discovery, development, research, and regulatory submissions. We offer solutions that bridge artificial intelligence (AI)/machine learning, physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, and regulatory agencies worldwide. For more information, visit our website at www.simulations-plus.com. Follow us on LinkedIn | X | YouTube.

Environmental, Social, and Governance (ESG)

We focus our Environmental, Social, and Governance (ESG) efforts where we can have the most positive impact. To learn more about our latest initiatives and priorities, please visit our website to read our 2023 ESG update.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240522828400/en/

Simulations Plus Investor Relations

Renee Bouche

661-723-7723

renee.bouche@simulations-plus.com

Financial Profiles

Lisa Fortuna

310-622-8251

slp@finprofiles.com

Source: Simulations Plus, Inc.

FAQ

When is Simulations Plus participating in the Craig-Hallum Institutional Investor Conference?

Simulations Plus will participate on May 29, 2024.

What will the CEO of Simulations Plus do at the Craig-Hallum conference?

CEO Shawn O'Connor will host one-on-one and small group meetings.

What is the significance of Simulations Plus attending the Craig-Hallum Institutional Investor Conference?

It increases the company's visibility among institutional investors and offers direct engagement opportunities.

How many companies will participate in the 21st Annual Craig-Hallum Institutional Investor Conference?

The conference features more than 130 public companies.

Where is the Craig-Hallum Institutional Investor Conference held?

The conference is held in Minneapolis, MN.